Bragg F , Holmes MV , Iona A , Guo Y , Du H , Chen Y , et al . Association between diabetes and cause-specific mortality in rural and urban areas of China . JAMA . 2017 ; 317 ( 3 ): 280 - 9 .
Qiu ZX , Qian F , Zhang YB , Liu J , Geng TT , Li R , et al . Risk factor control in relation to mortality and life expectancy among people with type 2 diabetes: results from 3 nationwide cohort studies . Mil Med Res . 2025 ; 12 ( 1 ): 89 .
Lean ME , Leslie WS , Barnes AC , Brosnahan N , Thom G , McCombie L , et al . Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial . Lancet . 2018 ; 391 ( 10120 ): 541 - 51 .
Taheri S , Zaghloul H , Chagoury O , Elhadad S , Ahmed SH , El Khatib N , et al . Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial . Lancet Diabetes Endocrinol . 2020 ; 8 ( 6 ): 477 - 89 .
Bhaskaran K , Dos-Santos-Silva I , Leon DA , Douglas IJ , Smeeth L . Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3.6 million adults in the UK . Lancet Diabetes Endocrinol . 2018 ; 6 ( 12 ): 944 - 53 .
Iona A , Bragg F , Guo Y , Yang L , Chen Y , Pei P , et al . Adiposity and risks of vascular and non-vascular mortality among Chinese adults with type 2 diabetes: a 10-year prospective study . BMJ Open Diabetes Res Care . 2022 ; 10 ( 1 ): e002489 .
Lean ME , Leslie WS , Barnes AC , Brosnahan N , Thom G , McCombie L , et al . 5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study . Lancet Diabetes Endocrinol . 2024 ; 12 ( 4 ): 233 - 46 .
Frias JP , Davies MJ , Rosenstock J , Perez Manghi FC , Fernandez Lando L , Bergman BK , et al . Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes . N Engl J Med . 2021 ; 385 ( 6 ): 503 - 15 .
Lincoff AM , Brown-Frandsen K , Colhoun HM , Deanfield J , Emerson SS , Esbjerg S , et al . Semaglutide and cardiovascular outcomes in obesity without diabetes . N Engl J Med . 2023 ; 389 ( 24 ): 2221 - 32 .
The trial reading is over, you can activate your VIP account to continue reading.
Associations of different definitions of prediabetes and diabetes with all-cause and cause-specific mortality: a nationally representative cohort study
Risk factor control in relation to mortality and life expectancy among people with type 2 diabetes: results from 3 nationwide cohort studies
Metabolic syndrome and risk of sepsis and sepsis-related mortality: evidence from two large prospective cohort studies
Serum immunoglobulin G predicts mortality and stratifies intravenous immunoglobulin benefit in sepsis patients
Sepsis in burn care: incidence and outcomes
Related Author
Mei Zhang
Zi-Xin Qiu
Yue Wang
Xiao Zhang
Shi-Yu Zhao
Chun Li
Zhen-Ping Zhao
Shen-Han Xiang
Related Institution
National Center for Chronic and Noncommunicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention
Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, Ministry of Education Key Laboratory of Environment and Health, and State Key Laboratory of Environment Health (Incubating), School of Public Health, Tongji Medical College, Huazhong University of Science and Technology
Clinical Center for Human Genomic Research, Union Hospital, Huazhong University of Science and Technology
Hubei Clinical Research Center of Metabolic and Cardiovascular Disease, Huazhong University of Science and Technology
Hubei Key Laboratory of Metabolic Abnormalities and Vascular Aging, Huazhong University of Science and Technology